The majority of studies report on IFN-γ treatment of TB and demonstrate a reduction in pro-inflammatory cytokine production, enhancement of TB-specific CD4 T-cell responses, enhanced sputum conversion and reduced radiological involvement, although some inconsistent outcomes have been reported (Park et al., 2007; Dawson et al., 2009). Here, IFNG is linked to tuberculosis.